Geographic Distribution, Age Pattern and Sites of Lesions in a Cohort of Buruli Ulcer Patients from the Mapé Basin of Cameroon

PLoS Neglected Tropical Diseases

Volumn 7, Issue 6, 2013, Pages

  Bratschi, Martin W ^a,b   Bolz, Miriam ^a,b   Minyem, Jacques C ^a,c   Grize, Leticia ^a,b   Wantong, Fidèle G ^d   Kerber, Sarah ^a,b   Njih Tabah, Earnest ^a,b,e   Ruf, Marie Thérèse ^a,b   Mou, Ferdinand ^c   Noumen, Djeunga ^d   Um Boock, Alphonse ^c   Pluschke, Gerd ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c FAIRMED Africa Regional Office   (Cameroon)

^d Bankim District Hospital   (Cameroon)

^e MINISTRY OF PUBLIC HEALTH   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BURULI ULCER; CAMEROON; CHILD; COHORT ANALYSIS; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INTERVIEW; KNEE INJURY; LEPROSY; MALE; MORBIDITY; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SKIN DEFECT; YAWS; AGE; AGED; CROSS-SECTIONAL STUDY; INFANT; ISOLATION AND PURIFICATION; MIDDLE AGED; MYCOBACTERIUM ULCERANS; PATHOLOGY; RISK FACTOR; TOPOGRAPHY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BURULI ULCER; CAMEROON; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MYCOBACTERIUM ULCERANS; RISK FACTORS; TOPOGRAPHY, MEDICAL; YOUNG ADULT;

EID: 84879543479     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002252     Document Type: Article

References (61)

1. Maccallum P, Tolhurst JC, Buckle G, Sissons HA, (1948) A new mycobacterial infection in man. The Journal of Pathology and Bacteriology 60: 93-122 doi:10.1002/path.1700600111.
2. Rondini S, Käser M, Stinear T, Tessier M, Mangold C, et al. (2007) Ongoing genome reduction in Mycobacterium ulcerans. Emerging Infect Dis 13: 1008-1015.
3. Käser M, Rondini S, Naegeli M, Stinear T, Portaels F, et al. (2007) Evolution of two distinct phylogenetic lineages of the emerging human pathogen Mycobacterium ulcerans. BMC Evol Biol 7: 177 doi:10.1186/1471-2148-7-177.
4. Doig KD, Holt KE, Fyfe JA, Lavender CJ, Eddyani M, et al. (2012) On the origin of Mycobacterium ulcerans, the causative agent of buruli ulcer. BMC genomics 13: 258 doi:10.1186/1471-2164-13-258.
5. Portaels F, Silva MT, Meyers WM, (2009) Buruli ulcer. Clin Dermatol 27: 291-305 doi:10.1016/j.clindermatol.2008.09.021.
6. Noeske J, Kuaban C, Rondini S, Sorlin P, Ciaffi L, et al. (2004) Buruli ulcer disease in Cameroon rediscovered. Am J Trop Med Hyg 70: 520-526.
7. Marion E, Landier J, Boisier P, Marsollier L, Fontanet A, et al. (2011) Geographic expansion of Buruli ulcer disease, Cameroon. Emerging Infect Dis 17: 551-553 doi:10.3201/eid1703.091859.
8. Jacobsen KH, Padgett JJ, (2010) Risk factors for Mycobacterium ulcerans infection. International Journal of Infectious Diseases 14: e677-e681 doi:10.1016/j.ijid.2009.11.013.
9. Walsh DS, Portaels F, Meyers WM, (2011) Buruli Ulcer: Advances in Understanding Mycobacterium ulcerans Infection. Dermatologic Clinics 29: 1-8 doi:10.1016/j.det.2010.09.006.
10. Merritt RW, Walker ED, Small PLC, Wallace JR, Johnson PDR, et al. (2010) Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis 4: e911 doi:10.1371/journal.pntd.0000911.
11. World Health Organization (2000) Buruli ulcer Mycobacterium ulcerans infection. Available: http://whqlibdoc.who.int/hq/2000/who_cds_cpe_gbui_2000.1.pdf. Accessed 03 May 2012.
12. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, et al. (1999) Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283: 854-857.
13. World Health Organization (2012) Buruli ulcer (Mycobacterium ulcerans infection) Fact sheet N°199. Available: http://www.who.int/mediacentre/factsheets/fs199/en/. Accessed 18 December 2012.
14. World Health Organization (2004) Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). Available: http://www.who.int/buruli/information/antibiotics/en/index.html. Accessed 03 May 2013.
15. Adu E, Ampadu E, Acheampong D, (2011) Surgical Management of Buruli Ulcer Disease: A Four-Year Experience from Four Endemic Districts in Ghana. Ghana Med J 45: 4-9.
16. Ruf M-T, Sopoh GE, Brun LV, Dossou AD, Barogui YT, et al. (2011) Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue? PLoS Negl Trop Dis 5: e1334 doi:10.1371/journal.pntd.0001334.
17. Walker SL, Hay RJ, (2000) Yaws-a review of the last 50 years. Int J Dermatol 39: 258-260.
18. Antal GM, Lukehart SA, Meheus AZ, (2002) The endemic treponematoses. Microbes Infect 4: 83-94.
19. Suzuki K, Akama T, Kawashima A, Yoshihara A, Yotsu RR, et al. (2012) Current status of leprosy: epidemiology, basic science and clinical perspectives. J Dermatol 39: 121-129 doi:10.1111/j.1346-8138.2011.01370.x.
20. Jacobson RR, Krahenbuhl JL, (1999) Leprosy. Lancet 353: 655-660 doi:10.1016/S0140-6736(98)06322-3.
21. Eddyani M, Fraga AG, Schmitt F, Uwizeye C, Fissette K, et al. (2009) Fine-needle aspiration, an efficient sampling technique for bacteriological diagnosis of nonulcerative Buruli ulcer. J Clin Microbiol 47: 1700-1704 doi:10.1128/JCM.00197-09.
22. Fyfe JAM, Lavender CJ, Johnson PDR, Globan M, Sievers A, et al. (2007) Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol 73: 4733-4740 doi:10.1128/AEM.02971-06.
23. Lavender CJ, Fyfe JAM, (2013) Direct Detection of Mycobacterium ulcerans in Clinical Specimens and Environmental Samples. Methods Mol Biol 943: 201-216 doi:_10.1007/978-1-60327-353-4_13.
24. US EPA National Center for Environmental Assessment WD, Moya J (n.d.) Exposure Factors Handbook 2011 Edition (Final). Available:http://cfpub.epa.gov/ncea/risk/recordisplay.cfm?deid=236252#Download. Accessed 1 November 2012.
25. National Institute of Statistics Republic of Cameroon (2012) Demographic and Health survey and Multiple Indicators Cluster Survey DHS-MICS 2011: Preliminary Report. Available: http://www.statistics-cameroon.org/downloads/EDS-MICS11/DHSMICS_2011_preliminary_report.pdf. Accessed 10 December 2012.
26. Bartram J, Cairncross S, (2010) Hygiene, sanitation, and water: forgotten foundations of health. PLoS Med 7: e1000367 doi:10.1371/journal.pmed.1000367.
27. Cairncross S, Blumenthal U, Kolsky P, Moraes L, Tayeh A, (1996) The public and domestic domains in the transmission of disease. Trop Med Int Health 1: 27-34.
28. The International Federation of Anti-Leprosy Associations (2012) Cameroon The History of Leprosy in this Country. Available: http://www.ilep.org.uk/ilep-co-ordination/leprosy-around-the-world/africa/cameroon/. Accessed 11 December 2012.
29. World Health Organization (2012) Weekly Epidemiological Record 18 May 2012, vol. 87, 20 (pp 189-200). Available: http://www.who.int/wer/2012/wer8720/en/index.html. Accessed 11 December 2012.
30. World Health Organization (2010) First WHO Report on Neglected Tropical Diseases. Available: http://www.who.int/neglected_diseases/2010report/en/index.html. Accessed 5 December 2012.
31. Maurice J, (2012) WHO plans new yaws eradication campaign. The Lancet 379: 1377-1378 doi:10.1016/S0140-6736(12)60581-9.
32. Mitjà O, Hays R, Ipai A, Penias M, Paru R, et al. (2012) Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial. The Lancet 379: 342-347 doi:10.1016/S0140-6736(11)61624-3.
33. Kanga JM, Kacou ED, (2001) [Epidemiologicl aspects of Buruli ulcer in Côte d'Ivoire: results of a national survey]. Bull Soc Pathol Exot 94: 46-51.
34. Amofah G, Bonsu F, Tetteh C, Okrah J, Asamoa K, et al. (2002) Buruli ulcer in Ghana: results of a national case search. Emerging Infect Dis 8: 167-170 doi:10.3201/eid0802.010119.
35. Marston BJ, Diallo MO, Horsburgh CR, Diomande I, Saki MZ, et al. (1995) Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire. Am J Trop Med Hyg 52: 219-224.
36. Amofah GK, Sagoe-Moses C, Adjei-Acquah C, Frimpong EH, (1993) Epidemiology of Buruli ulcer in Amansie West district, Ghana. Trans R Soc Trop Med Hyg 87: 644-645.
37. Porten K, Sailor K, Comte E, Njikap A, Sobry A, et al. (2009) Prevalence of Buruli ulcer in Akonolinga health district, Cameroon: results of a cross sectional survey. PLoS Negl Trop Dis 3: e466 doi:10.1371/journal.pntd.0000466.
38. Phanzu DM, Bafende EA, Dunda BK, Imposo DB, Kibadi AK, et al. (2006) Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004. Am J Trop Med Hyg 75: 311-314.
39. Saka B, Landoh DE, Kobara B, Djadou KE, Yaya I, et al. (2012) [Profile of Buruli ulcer treated at the National Reference Centre of Togo: a study of 119 cases.]. Bull Soc Pathol Exot doi:10.1007/s13149-012-0241-1.
40. Mensah-Quainoo E, Yeboah-Manu D, Asebi C, Patafuor F, Ofori-Adjei D, et al. (2008) Diagnosis of Mycobacterium ulcerans infection (Buruli ulcer) at a treatment centre in Ghana: a retrospective analysis of laboratory results of clinically diagnosed cases. Trop Med Int Health 13: 191-198 doi:10.1111/j.1365-3156.2007.01990.x.
41. Bratschi MW, Njih Tabah E, Bolz M, Stucki D, Borrell S, et al. (2012) A case of cutaneous tuberculosis in a Buruli ulcer-endemic area. PLoS Negl Trop Dis 6: e1751 doi:10.1371/journal.pntd.0001751.
42. Bretzel G, Huber KL, Kobara B, Beissner M, Piten E, et al. (2011) Laboratory confirmation of Buruli ulcer disease in Togo, 2007-2010. PLoS Negl Trop Dis 5: e1228 doi:10.1371/journal.pntd.0001228.
43. Yeboah-Manu D, Asante-Poku A, Asan-Ampah K, Ampadu EDE, Pluschke G, (2011) Combining PCR with microscopy to reduce costs of laboratory diagnosis of buruli ulcer. Am J Trop Med Hyg 85: 900-904 doi:10.4269/ajtmh.2011.11-0362.
44. Raghunathan PL, Whitney EAS, Asamoa K, Stienstra Y, Taylor TH, et al. (2005) Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana. Clin Infect Dis 40: 1445-1453 doi:10.1086/429623.
45. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, et al. (2004) Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health 9: 1297-1304 doi:10.1111/j.1365-3156.2004.01339.x.
46. Johnson PDR, Azuolas J, Lavender CJ, Wishart E, Stinear TP, et al. (2007) Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerging Infect Dis 13: 1653-1660.
47. Agarwal S, Busse PJ, (2010) Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol 104: 183-190 quiz 190-192, 210. doi:10.1016/j.anai.2009.11.009.
48. Stienstra Y, Van Der Graaf WTA, Te Meerman GJ, The TH, De Leij LF, et al. (2001) Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors. Tropical Medicine & International Health 6: 554-562 doi:10.1046/j.1365-3156.2001.00746.x.
49. Diaz D, Döbeli H, Yeboah-Manu D, Mensah-Quainoo E, Friedlein A, et al. (2006) Use of the immunodominant 18-kiloDalton small heat shock protein as a serological marker for exposure to Mycobacterium ulcerans. Clin Vaccine Immunol 13: 1314-1321 doi:10.1128/CVI.00254-06.
50. Yeboah-Manu D, Röltgen K, Opare W, Asan-Ampah K, Quenin-Fosu K, et al. (2012) Sero-epidemiology as a tool to screen populations for exposure to Mycobacterium ulcerans. PLoS Negl Trop Dis 6: e1460 doi:10.1371/journal.pntd.0001460.
51. Knols BG, Takken W, De Jong R, (1994) Influence of human breath on selection of biting sites by Anopheles albimanus. J Am Mosq Control Assoc 10: 423-426.
52. De Jong R, Knols BG, (1996) Selection of biting sites by mosquitoes. Ciba Found Symp 200: 89-100 discussion 101-108.
53. Dekker T, Takken W, Knols BGJ, Bouman E, Van de Laak S, et al. (1998) Selection of biting sites on a human host by Anopheles gambiae s.s., An. arabiensis and An. quadriannulatus. Entomologia Experimentalis et Applicata 87: 295-300 doi:10.1046/j.1570-7458.1998.00334.x.
54. De Jong R, Knols BG, (1995) Selection of biting sites on man by two malaria mosquito species. Experientia 51: 80-84.
55. DUKE BO, BEESLEY WN, (1958) The vertical distribution of Simulium damnosum bites on the human body. Ann Trop Med Parasitol 52: 274-281.
56. Hashiguchi Y, De Coronel VV, Gomez Landires EA (n.d.) An epidemiological study of Leishmaniasis in a plantation «cooperativa 23 de Febrero» newly established in Ecuador. Kiseichugaku Zasshi 33: 393-401.
57. KERSHAW WE, DUKE BO, BUDDEN FH, (1954) Distribution of microfilariae of O. volvulus in the skin; its relation to the skin changes and to eye lesions and blindness. Br Med J 2: 724-729.
58. Boyd SC, Athan E, Friedman ND, Hughes A, Walton A, et al. (2012) Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population. Med J Aust 196: 341-344.
59. Walsh DS, Portaels F, Meyers WM, (2010) Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection). Curr Opin Infect Dis 23: 445-455 doi:10.1097/QCO.0b013e32833c2209.
60. Hospers IC, Wiersma IC, Dijkstra PU, Stienstra Y, Etuaful S, et al. (2005) Distribution of Buruli ulcer lesions over body surface area in a large case series in Ghana: uncovering clues for mode of transmission. Trans R Soc Trop Med Hyg 99: 196-201 doi:10.1016/j.trstmh.2004.05.004.
61. Labbé J, Caouette G, (2001) Recent skin injuries in normal children. Pediatrics 108: 271-276.